Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche

作者：Govaere Olivier^*; Wouters Jasper; Petz Michaela; Vandewynckel Yves Paul; Van den Eynde Kathleen; Van den Broeck Anke; Verhulst Stefaan; Dolle Laurent; Gremeaux Lies; Ceulemans An; Nevens Frederik; van Grunsven Leo A; Topal Baki; Vankelecom Hugo; Giannelli Gianluigi; Van Vlierberghe Hans; Mikulits Wolfgang; Komuta Mina; Roskams Tania

来源：Journal of Hepatology, 2016, 64(3): 609-617.

DOI：10.1016/j.jhep.2015.11.011

• Hepatic cancer
• Cancer stem cell
• Microenvironment
• Niche
• Phenotype switching
• Extracellular matrix
• ATP-binding cassette transporters

Background & Aims: Cancer stem cells (CSCs) are thought to be persistent in tumours due to their chemoresistance and to cause relapse and metastasis. Hepatic carcinomas displaying hepatic progenitor cell (HPC) features have been associated with a poor prognosis, though it remains unclear how CSCs relate to these different histological subtypes.
Methods: Candidate CSCs were isolated using the side population (SP) technique from primary tissue samples diagnosed as keratin (K) 19-negative or -positive hepatocellular carcinoma (HCC) or as combined hepatocellular/cholangiocarcinoma and analysed for gene and protein expression. The effect of laminin-332 was analysed in vitro by using HCC cell lines and in vivo using a xenograft mouse model.
Results: The size of the SP correlated with the degree of HPC features found in human hepatic cancer, and also showed an elevated mRNA expression of biliary/HPC markers and the extracellular matrix marker LAMC2, the gene encoding the laminin c2-chain. Immunopositivity for the c2-chain of laminin-332 was seen in the extracellular matrix surrounding small HPC-like tumour cells with a low proliferation rate. In vitro, laminin-332 increased K19 expression, phosphorylated mTOR and decreased phospho-histone H3 expression, indicating reduced cell mitosis. The effect of laminin-332 was enhanced upon mTORC1 inhibition and diminished when inhibiting mTORC1+C2. Resistance to doxorubicin and sorafenib treatment, and the SP fraction increased in the coated condition. In vivo, laminin-332 reduced tumour growth and sustained K19 expression.
Conclusions: In this study we identified a prominent role for laminin-332 as part of the specialised CSC niche in maintaining and supporting cell 'stemness', which leads to chemoresistance and quiescence.

• 出版日期2016-3